drugset
drugset / Trial / NCT03945513

A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

NCT03945513 ↗

Phase 3 Completed 1034 enrolled Insud Pharma Chemo Research · collab
NaSingle-groupOpen-labelPrevention

Summary

The main objective of this trial is to demonstrate the contraceptive efficacy of LPRI424, Additional goals of the trial are to demonstrate the safety and tolerability of LPRI424.

Timeline

Start
2019-12-03
Primary completion
2023-06-30
Completion
2023-09-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral
Subject ethinyl estradiol Small molecule 0.02 mg Oral

Indications

No indication recorded.